Cell and advanced therapies supply chain management market, 2030 type-1

Given the cost saving potential across different processes and
operations, the cell and advanced therapies supply chain
management market is projected to grow at an annualized rate of
~25% rapid till 2030
Roots Analysis has done a detailed study on Cell and Advanced Therapies Supply
Chain Management Market: Focus on Technological Solutions (Cell
Orchestration Platforms, Enterprise Manufacturing Systems, Inventory
Management Systems, Laboratory Information Management Systems, Logistics
Management Systems, Patient Management Systems, Quality Management
Systems, Tracking & Tracing Systems, and Other Software), 2019-2030,
covering key aspects of the industry’s evolution and identifying potential future growth
opportunities.
To order this 510+ page report, which features 185+ figures and 400+ tables,
please visit this link
Key Market Insights
 Presently, over 160 innovative, software-enabled systems are being used to
efficiently manage and streamline various aspects of the complex supply chain of
cell and advanced therapies
 Company involved in this domain are putting in significant efforts to develop
advanced software solutions and also differentiate their offerings, from those of
other industry players, in order to maintain a competitive edge
 North America is the major hub of innovation in this field, serving as the base for
companies of all sizes, which are primarily engaged in developing cloud-based
solutions for diverse applications
 The cell and advanced therapies market is characterized by an elaborate value
chain, involving a multitude of processes and several stakeholders, each having a
discrete set of priorities and requirements
 Increase in partnership activity reflects the growing interest of stakeholders in
this industry; over 50% of reported deals were established to deploy software
solutions for enhancing visibility and supply chain performance
 An analysis of recent activity on Twitter reveals the increasing interest and
ongoing efforts of industry stakeholders in providing needle-to-needle traceability
and supply chain orchestration solutions
 Given their cost saving potential across different processes and operations, we
expect the cell and advanced therapy supply chain solutions market to grow at an
annualized rate of around 25% over the next decade
 In the mid-long term, the projected opportunity is anticipated to be well
distributed across various global regions, different end uses / applications and
mode of deployment of various proprietary software solutions
For more information, please visit
https://www.rootsanalysis.com/reports/view_document/cell-therapies-
supply-chain/260.html

Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. An Introduction to Cell and Advanced Therapies
3.2.1. Classification of Advanced Therapy Medicinal Products
3.2.2. Current Market Landscape
3.3. Overview of Cell and Advanced Therapies Supply Chain
3.3.1. Donor Eligibility and Selection
3.3.2. Sample Collection
3.3.3. Manufacturing
3.3.4. Logistics
3.3.5. Patient Verification and Treatment
3.3.6. Challenges Associated with the Cell and Advanced Therapies Supply Chain
3.3.6.1. Process Standardization
3.3.6.2. Packaging and Shipping Qualification
3.3.6.3. Validation of Storage Containers
3.3.6.4. Process Qualification
3.3.6.5. Chain of Custody Documentation
3.3.6.6. Demand Forecastin
3.4. Software Solutions for Cell and Advanced Therapies Supply Chain Management
3.4.1. Enterprise Manufacturing System
3.4.2. Laboratory Information Management System
3.4.3. Inventory Management System
3.4.4. Quality Management System
3.4.5. Logistics Management System
3.4.6. Patient Management System
3.4.7. Electronic Clinical Outcome Assessments System
3.4.8. Supply Chain Orchestration Platfor
3.5. Growth Drivers and Roadblocks
3.6. Recent Developments and Upcoming Trends
3.6.1. Blockchain Technology
3.6.2. Internet of Things
3.6.3. Augmented Reality
3.6.4. Big Data Analytics
3.6.5. Artificial Intelligence
4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Cell and Advanced Therapies Supply Chain Management: Overall Market
Landscape
4.2.1. Analysis by Type of Software Solution
4.2.2. Analysis by Key Specification and Benefits Offered
4.2.3. Analysis by Application
4.2.4. Analysis by Mode of Deployment
4.2.5. Analysis by Scale of Management
4.2.6. Analysis by Regulatory Certifications / Accreditations
4.2.7. Analysis by End User
4.3. Cell and Advanced Therapies Supply Chain Management: Developer Landscape

4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Location of Headquarters
4.3.3. Analysis by Company Size
4.3.4. Analysis by Support Services Offered
4.3.5. Leading Developers: Analysis by Number of Software Solutions
5. COMPANY COMPETITIVENESS ANALYSIS
5.2. Methodology
5.3. Assumptions and Key Input Parameters
5.4. Competitiveness Analysis: Software Solution Providers
5.4.1. COP Developers
5.4.2. EMS Developers
5.4.3. IMS Developers
5.4.4. LIMS Developers
5.4.5. LMS Developers
5.4.6. PMS Developers
5.4.7. QMS Developers
5.4.8. TTS Developers
6. CELL AND ADVANCED THERAPIES SUPPLY CHAIN MANAGEMENT: COMPANY
PROFILES
6.2. Brooks Life Sciences
6.2.1. Company Overview
6.2.2. Supply Chain Management Software Solution Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Cryoport
6.3.2. Financial Information
6.4. MasterControl
6.5. SAP
6.6. Savsu Technologies
6.6.4. Recent Development and Future Outlook
6.7. TraceLink
7. SUPPLY CHAIN ORCHESTRATION PLATFORM: EMERGING TRENDS AND KEY
PLAYERS
7.2. Supply Chain Orchestration Platforms
7.2.1. Key Functions of Supply Chain Orchestration Platforms

7.2.2. Advantages of Supply Chain Orchestration Platforms
7.2.3. Supply Chain Orchestration Platform Implementation Strategies
7.2.3.1. Building the Required Foundation
7.2.3.2. Incorporating an Appropriate Scheduling System
7.2.3.3. Integration with Core Systems / Processe
7.3. Supply Chain Orchestration Platform: Social Media Trends
7.3.1. Scope and Methodology
7.3.2. Historical Trends in Volume of Tweets
7.3.3. Popular Keyword
7.4. Key Industry Players
7.4.1. Be The Match BioTherapies®
7.4.1.1. Company Overview
7.4.1.2. Financial Information
7.4.1.3. MatchSource®: Software Description
7.4.1.4. Recent Developments and Future Outloo
7.4.2. Clarkston Consulting
7.4.2.2. Cell Therapy Orchestration Platform: Software Description
7.4.3. Haemonetics
7.4.3.3. EdgeCell®: Software Description
7.4.3.4. Recent Developments and Future Outlook
7.4.4. Hypertrust Patient Data Care
7.4.4.2. Hypertrust X-Chain: Software Description
7.4.5. Lykan Bioscience
7.4.5.2. Unnamed Software: Software Description
7.4.6. MAK-SYSTEM
7.4.6.2. T.C.S.: Software Description
7.4.7. sedApta
7.4.7.2. O.S.A.: Software Description
7.4.8. Stafa Cellular Therapy
7.4.8.2. Stafa Cellular Therapy Lab: Software Description
7.4.9. Title 21 Health Solutions
7.4.9.2. Cell Therapy Software: Software Description
7.4.10. TrakCel
7.4.10.3. Cell Orchestration Platform: Software Description

7.4.11. Vineti
7.4.11.3. Personalized Therapy Management Platform: Software Description
8. FUNDING AND INVESTMENT ANALYSIS
8.2. Types of Funding
8.3. Cell and Advanced Therapies Supply Chain Management: Funding and
Investment Analysis
8.3.1. Analysis by Number of Funding Instances
8.3.2. Analysis by Amount Invested
8.3.3. Analysis by Type of Funding
8.3.4. Analysis by Number of Funding Instances and Amount Invested across
Different Software Solutions
8.3.5. Most Active Players: Analysis by Number of Funding Instances
8.3.6. Most Active Investors: Analysis by Number of Funding Instances
8.3.7. Geographical Analysis by Amount Invested
8.4. Concluding Remarks
9. PARTNERSHIPS AND COLLABORATIONS
9.2. Partnership Models
9.3. Cell and Advanced Therapies Supply Chain Management: Recent Collaborations
and Partnerships
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Partner’s Focus Area
9.3.3.1. Analysis by Partner’s Focus Area
9.3.3.2. Analysis by Type of Platform and Partner’s Focus Area
9.3.3.3. Analysis by Type of Partnership Model and Partner’s Focus Area
9.3.4. Software Solution Analysis
9.3.4.1. Analysis by Type of Software Solutions
9.3.4.2. Analysis by Type of Platform and Partnership Model
9.3.5. Most Active Players: Analysis by Number of Partnerships
9.3.6. Geographical Analysis
9.3.6.1. Most Active Players
9.3.6.2. Intercontinental and Intracontinental Agreements
10.SUPPLY CHAIN UTILIZATION USE CASES
10.2. Cell and Advanced Therapies Supply Chain Management: Recent Platform
Utilization Use Cases
10.2.1. Analysis by Year of Utilization
10.2.2. Analysis by Type of Partner
10.2.2.1. Most Active Users: Distribution by Number of Platform Utilization
Instances
10.2.2.2. Geographical Distribution of Users
10.2.3. Analysis by Type of Software Solution
10.2.4. Most Active Players: Analysis by Number of Platform Utilization
Agreements
10.2.5. Most Active Players: Regional Analysis by Number of Platform
Utilization Agreements

10.2.5.1. Regional Distribution by Type of Software Solutions
10.2.5.2. Intercontinental and Intracontinental Agreements
11.STAKEHOLDER NEEDS ANALYSIS
11.2. Cell and Advanced Therapies Supply Chain Management: Needs of
Different Stakeholders
11.2.1. Comparison of Stakeholder Needs
12.COST SAVINGS ANALYSIS
12.2. Key Assumptions and Methodology
12.3. Overall Cost Saving Potential of Supply Chain Management Software
Solutions, 2019-2030
12.3.1. Cost Saving Potential in Sample Collection and Processing, 2019-
2030
12.3.2. Cost Saving Potential in Manufacturing, 2019-2030
12.3.3. Cost Saving Potential in Logistics, 2019-2030
12.3.4. Cost Saving Potential in Patient Verification and Treatment Follow-
up, 2019-2030
13.MARKET FORECAST
13.2. Key Assumptions and Forecast Methodology
13.3. Overall Cell and Advanced Therapies Supply Chain Management Solutions
Market, 2019-2030
13.3.1. Overall Cell and Advanced Therapies Supply Chain Management
Solutions Market: Distribution by Application
13.3.1.1. Cell and Advanced Therapies Supply Chain Management Solutions
Market for Sample Collection and Processing, 2019-2030
Market for, Manufacturing, 2019-2030
Market for, Logistics, 2019-2030
Market for Patient Verification and Treatment Follow-up, 2019-2030
Solutions Market: Distribution by End User
Market for Biobanks, 2019-2030
Market for Cell Therapy Labs / Commercial Organizations, 2019-2030
Market for Hospitals / Medical Centers, 2019-2030
Market for Research Institutes, 2019-2030
Solutions Market: Distribution by Type of Software Solution
13.3.3.1. Cell Orchestration Platforms Market for Cell and Advanced
Therapies Supply Chain Management, 2019-2030
13.3.3.2. Enterprise Manufacturing Systems Market for Cell and Advanced
13.3.3.3. Inventory Management Systems Market for Cell and Advanced
13.3.3.4. Laboratory Information Management Systems Market for Cell and
Advanced Therapies Supply Chain Management, 2019-2030

13.3.3.5. Logistics Management Systems Market for Cell and Advanced
13.3.3.6. Patient Management Systems Market for Cell and Advanced
13.3.3.7. Quality Management Systems Market for Cell and Advanced
Solutions Market: Distribution by Mode of Deployment
13.3.4.1. Cell and Advanced Therapies Supply Chain Management Market for
Cloud-based Solutions, 2019-2030
On-premises Solutions, 2019-2030
Solutions Market: Distribution by Scale of Operation
Clinical Therapies, 2019-2030
Commercial Therapies, 2019-2030
Solutions Market: Distribution by Geography
Market in North America, 2019-2030
Market in Europe, 2019-2030
Market in Asia-Pacific, 2019-2030
Market in Rest of the World, 2019-2030
13.4. Overall Cell and Advanced Therapies Supply Chain Management Solutions
Market: Distribution by Application, Type of Software Solution and Mode of
Deployment
13.4.1. Cell and Advanced Therapies Supply Chain Management Solutions
Market for Sample Collection and Processing, 2019-2030
13.4.1.1. Cell Orchestration Platforms Market for Sample Collection and
Processing, 2019-2030
13.4.1.1.1. Cell Orchestration Platforms Market for Sample Collection
and Processing: Cloud-based Solutions, 2019-2030
13.4.1.1.2. Cell Orchestration Platforms Market for Sample Collection
and Processing: On-premises Solutions, 2019-2030
13.4.1.2. Enterprise Manufacturing Systems Market for Sample Collection
and Processing, 2019-2030
13.4.1.2.1. Enterprise Manufacturing Systems Market for Sample
Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.2.2. Enterprise Manufacturing Systems Market for Sample
Collection and Processing: On-premises Solutions, 2019-2030
13.4.1.3. Inventory Management Systems Market for Sample Collection and
13.4.1.3.1. Inventory Management Systems Market for Sample
Collection and Processing: Cloud-based Solutions, 2019-2030
13.4.1.3.2. Inventory Management Systems Market for Sample
Collection and Processing: On-premises Solutions, 2019-2030

13.4.1.4. Laboratory Information Management Systems Market for Sample
Collection and Processing, 2019-2030
13.4.1.4.1. Laboratory Information Management Systems Market for
Sample Collection and Processing: Cloud-based Solutions, 2019-
2030
Sample Collection and Processing: On-premises Solutions, 2019-
2030
13.4.1.5. Logistics Management Systems Market for Sample Collection and
13.4.1.5.1. Logistics Management Systems Market for Sample Collection
13.4.1.5.2. Logistics Management Systems Market for Sample Collection
13.4.1.6. Patient Management Systems Market for Sample Collection and
13.4.1.6.1. Patient Management Systems Market for Sample Collection
13.4.1.6.2. Patient Management Systems Market for Sample Collection
13.4.1.7. Quality Management Systems Market for Sample Collection and
13.4.1.7.1. Quality Management Systems Market for Sample Collection
13.4.1.7.2. Quality Management Systems Market for Sample Collection
Market for Manufacturing, 2019-2030
13.4.2.1. Cell Orchestration Platforms Systems Market for Manufacturing,
2019-2030
13.4.2.1.1. Cell Orchestration Platforms Systems Market for
Manufacturing: Cloud-based Solutions, 2019-2030
13.4.2.1.2. Cell Orchestration Platforms Systems Market for
Manufacturing: On-premises Solutions, 2019-2030
13.4.2.2. Enterprise Manufacturing Systems Market for Manufacturing, 2019-
2030
13.4.2.2.1. Enterprise Manufacturing Systems Market for
13.4.2.2.2. Enterprise Manufacturing Systems Market for
13.4.2.3. Inventory Management Systems Market for Manufacturing, 2019-
2030
13.4.2.3.1. Inventory Management Systems Market for Manufacturing:
13.4.2.3.2. Inventory Management Systems Market for Manufacturing:
13.4.2.4. Laboratory Information Management Systems Market for
Manufacturing, 2019-2030

13.4.2.5. Logistics Management Systems Market for Manufacturing, 2019-
2030
13.4.2.5.1. Logistics Management Systems Market for Manufacturing:
13.4.2.5.2. Logistics Management Systems Market for Manufacturing:
13.4.2.6. Patient Management Systems Market for Manufacturing, 2019-2030
13.4.2.6.1. Patient Management Systems Market for Manufacturing:
13.4.2.6.2. Patient Management Systems Market for Manufacturing: On-
premises Solutions, 2019-2030
13.4.2.7. Quality Management Systems Market for Manufacturing, 2019-
2030
13.4.2.7.1. Quality Management Systems Market for Manufacturing:
13.4.2.7.2. Quality Management Systems Market for Manufacturing:
Market for Logistics, 2019-2030
13.4.3.1. Cell Orchestration Platforms Market for Logistics, 2019-2030
13.4.3.1.1. Cell Orchestration Platforms Market for Logistics: Cloud-
based Solutions, 2019-2030
13.4.3.1.2. Cell Orchestration Platforms Market for Logistics: On-
13.4.3.2. Enterprise Manufacturing Systems Market for Logistics, 2019-2030
13.4.3.2.1. Enterprise Manufacturing Systems Market for Logistics:
13.4.3.2.2. Enterprise Manufacturing Systems Market for Logistics: On-
13.4.3.3. Inventory Management Systems Market for Logistics, 2019-2030
13.4.3.3.1. Inventory Management Systems Market for Logistics: Cloud-
13.4.3.3.2. Inventory Management Systems Market for Logistics: On-
13.4.3.4. Laboratory Information Management Systems Market for Logistics,
2019-2030
Logistics: Cloud-based Solutions, 2019-2030
Logistics: On-premises Solutions, 2019-2030
13.4.3.5. Logistics Management Systems Market for Logistics, 2019-2030
13.4.3.5.1. Logistics Management Systems Market for Logistics: Cloud-
13.4.3.5.2. Logistics Management Systems Market for Logistics: On-
13.4.3.6. Patient Management Systems Market for Logistics, 2019-2030
13.4.3.6.1. Patient Management Systems Market for Logistics: Cloud-

13.4.3.6.2. Patient Management Systems Market for Logistics: On-
Market for Patient Verification and Treatment Follow-up, 2019-2030
13.4.4.1. Cell Orchestration Platforms Market for Patient Verification and
Treatment Follow-up, 2019-2030
13.4.4.1.1. Cell Orchestration Platforms Market for Patient Verification
and Treatment Follow-up: Cloud-based Solutions, 2019-2030
13.4.4.1.2. Cell Orchestration Platforms Market for Patient Verification
and Treatment Follow-up: On-premises Solutions, 2019-2030
13.4.4.2. Inventory Management Systems Market for Patient Verification and
13.4.4.2.1. Inventory Management Systems Market for Patient
Verification and Treatment Follow-up: Cloud-based Solutions,
2019-2030
13.4.4.2.2. Inventory Management Systems Market for Patient
Verification and Treatment Follow-up: On-premises Solutions,
2019-2030
13.4.4.3. Patient Management Systems Market for Patient Verification and
13.4.4.3.1. Patient Management Systems Market for Patient Verification
and Treatment Follow-up: Cloud-based Solutions, 2019-2030
13.4.4.3.2. Patient Management Systems Market for Patient Verification
and Treatment Follow-up: On-premises Solutions, 2019-2030
14.EXECUTIVE INSIGHTS
14.2. Thermo Fisher Scientific
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Bryan Poltilove, Former General Manager, Cell
and Gene Therapy
14.3. Cell and Gene Therapy Catapult
14.3.2. Interview Transcript: Jacqueline Barry, Chief Clinical Officer
14.4. McKesson
14.4.2. Interview Transcript: Divya Iyer, Senior Director, Corporate
Strategy and Business Development, and Jill Maddux, Director, Cell and
Gene Therapy Product Strategy
14.5. TrakCel
14.5.2. Interview Transcript: Martin Lamb, Former Chief Business Officer
15.CONCLUDING REMARKS
15.2. Key Takeaways
16.APPENDIX 1: LIST OF ADDITIONAL SUPPLY CHAIN MANAGEMENT SOFTWARE
SOLUTIONS
17.APPENDIX 2: TABULATED DATA
18.APPENDIX 3: LIST OF COMPANIES AND ORGANIZATIONS
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh
and independent perspectives in the bio-pharmaceutical industry. The in-depth research,
analysis and insights are driven by an experienced leadership team which has gained

many years of significant experience in this sector. If you’d like help with your growing
business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com

Cell and advanced therapies supply chain management market, 2030 type-1

Recommended

Recommended

More Related Content

What's hot

What's hot (15)

Similar to Cell and advanced therapies supply chain management market, 2030 type-1

Similar to Cell and advanced therapies supply chain management market, 2030 type-1 (20)

Recently uploaded

Recently uploaded (20)

Cell and advanced therapies supply chain management market, 2030 type-1